2 hrs ago | MarketWatch
Novartis licenses Hepatitis C drug
It's been licensed from Debiopharm Group, an independent biopharmaceuticals company based in Switzerland, under an agreement which gives Novartis exclusive worldwide development and marketing rights outside of Japan.
Mon Feb 8, 2010 10:50am EST - A medical assistant injects a vaccine in a file photo.
The liver processes your body's waste products and detoxifies harmful substances that you ingest, such as alcohol.
Early treatment improves outcomes in acute hepatitis C virus infection
Early treatment improves outcomes in acute hepatitis C virus infection, finds the most recent issue of the Journal of Viral Hepatitis.
Lost Journal: Blacklisted by the Red Cross
Journal entry: Dec. 2, 1988 I care to belong to any club that won't accept people like me as members.
Liver Lines - February 5, 2010
At the start of this new decade, liver disease continues to be major source of morbidity and mortality both at home and around the world.
NVHR: Stop Liver Cancer 'Dead in Its Tracks' By Closing Funding Gap...
NVHR made the comments in conjunction with World Cancer Day 2010 , which is being observed today and led by the International Union Against Cancer.
Seven test positive for Hepatitis E in Shimla
India Gazette Friday 29th January, 2010 Seven blood samples of jaundice patients in the Himachal Pradesh state capital have tested positive for Hepatitis E - the first incidence of the virus spread liver disease in the state, a health official said Friday.
Achillion Rises on Hepatitis/HIV Drug Pact
Shares of Achillion Pharmaceuticals Inc. advanced Tuesday after the company said it entered a partnership to develop and sell its hepatitis B and HIV drug candidate elvucitabine in China and other territories.
Centers for Disease Control and Preve...
Hemorrhagic Fever with Renal Syndrome, Vietnam
Author affiliations: Pasteur Institute, Ho Chi Minh City, Vietnam ; Hokkaido University Graduate School of Medicine, Sapporo, Japan ; World Health Organization Technical Office, Ho Chi Minh City ; and Vietnam Field Epidemiology Training Program Office, Hanoi, Vietnam To the Editor: Hantaviruses are primarily rodentborne and can cause hemorrhagic ...
Report on hepatitis B & C market dynamics in China, South Korea, Taiwan and Turkey
Research and Markets has announced the addition of the "Stakeholder Insight: Hepatitis B & C in Asia - China, South Korea, Taiwan and Turkey" report to their offering.
Planning a winter getaway? How to avoid malaria
Home : Top Stories : Planning a winter getaway? How to avoid malaria Planning a winter getaway? How to avoid malaria Angela Mulholland, CTV.ca News Date: Saturday Jan.
Babies go into shock after vaccination in Ben Tre,
Doctors in the Mekong Delta province of Ben Tre are treating two babies who suffered shock after being given three different vaccines on Monday, the director of a local hospital said.
Lab advance aids hepatitis fight
Scientists looking for a treatment for a dangerous liver virus have found new ways to study it in the laboratory.
Bharatbook.com : Hepatitis B & C in Asia - China, South Korea, Taiwan and Turkey
Stakeholder Insight: Hepatitis B & C in Asia - China, South Korea, Taiwan and Turkey China, Taiwan, South Korea and Turkey represent highly endemic areas for viral Hepatitis.
Study confirms accuracy of transient elastography in NAFLD
Researchers from France and Hong Kong determined that transient elastography , a noninvasive, ultrasonic imaging modality, can be accurately performed in the majority of patients with nonalcoholic fatty liver disease to exclude advanced fibrosis.
Many unaware they have hepatitis B or C
As many as 5.3 million people in the United States have hepatitis B or C but most are unaware until they develop liver cancer or liver disease, researchers say.
Study: Threat of Hepatitis Underestimated
How's this for an unsettling statistic: up to 1 in 50 Americans are living with chronic viral hepatitis, but most of them don't know it.
Dynavax Reports Positive Phase 1b Data for SD-101 in Chronic Hepatitis C Infection
Dynavax Technologies Corporation announced today data from two studies that differentiate SD-101 from standard-of-care as well as emerging treatments for chronic HCV infection.
Engineering a new way to study hepatitis C
Researchers at MIT and Rockefeller University have successfully grown hepatitis C virus in otherwise healthy liver cells in the laboratory, an advance that could allow scientists to develop and test new treatments for the disease.
Also on Topix